Potential for Disease and Disorders

Waste and fluid accumulation in the fascia and muscles can give rise to a variety of diseases and disorders, including myofascial pain syndrome and fibromyalgia. Their detection and diagnosis are essential for effective treatment and prevention.

a. Myofascial Pain Syndrome

Myofascial Pain Syndrome (MPS) is a common musculoskeletal disorder characterized by pain emanating from myofascial trigger points—hyperirritable spots within a taut band of skeletal muscle or fascia. These trigger points can be a source of local and referred pain and are often associated with a dysfunctional motor endplate, where nerve signals are transmitted to muscles (Simons et al., 1999).

The etiology of MPS is multifactorial, with contributing factors including muscle overload, direct trauma, poor posture, and psychological stress. Moreover, metabolic waste accumulation might play a role in the pathophysiology of MPS. One proposed mechanism is that sustained muscle contraction due to stress or overuse can lead to compromised blood flow, promoting the build-up of metabolites like lactic acid and causing local hypoxia. This might trigger a cascade of inflammatory and pain responses, leading to the formation of myofascial trigger points (Shah et al., 2008).

b. Fibromyalgia

Fibromyalgia is a complex chronic pain disorder characterized by widespread pain, fatigue, sleep disturbances, and cognitive difficulties. It affects an estimated 2-8% of the population, with a higher prevalence in women than men (Clauw, 2014).

The exact cause of fibromyalgia remains unknown. However, it’s postulated that it results from a combination of genetic, environmental, and psychological factors leading to abnormal pain processing by the central nervous system.

The role of waste and fluid accumulation in fibromyalgia is not yet well-understood. However, research suggests that some patients with fibromyalgia exhibit signs of localized edema and an increased concentration of inflammatory cytokines in their muscles, indicating an inflammatory response (Lund et al., 2010). These observations suggest a potential role for waste and fluid accumulation in the pathogenesis or exacerbation of fibromyalgia symptoms, but further research is necessary to clarify these relationships.

C. Detection and Diagnosis of Waste and Fluid Accumulation

The detection and diagnosis of waste and fluid accumulation in fascia and muscles can be challenging due to the lack of specific symptoms. Usually, a combination of physical examination and imaging techniques is used.

Physical examination for MPS often involves palpation to locate myofascial trigger points and assess pain response. The practitioner may also look for signs of muscle weakness, restricted movement, and posture abnormalities (Alvarez & Rockwell, 2002).

In cases of suspected fibromyalgia, a comprehensive pain assessment is typically carried out. The American College of Rheumatology’s 2010 diagnostic criteria for fibromyalgia, for instance, require the presence of widespread pain along with a certain level of symptom severity across various domains (Wolfe et al., 2010).

Imaging modalities such as ultrasound, MRI, and CT scan can also be useful in visualizing fluid accumulation and inflammation. However, these methods might not detect smaller or more subtle changes in tissue composition (Turrina et al., 2013).

Blood tests may be used to identify signs of inflammation or metabolic imbalances that might indicate underlying pathology. In recent years, novel techniques such as microdialysis, which allows for the direct measurement of metabolic substances in the muscle, have shown promise for the detection of metabolic waste accumulation (Shah & Gilliams, 2008).


  1. Simons, D. G., Travell, J. G., & Simons, L. S. (1999). Travell & Simons’ myofascial pain and dysfunction: the trigger point manual (Vol. 1). Lippincott Williams & Wilkins.
  2. Shah, J. P., Danoff, J. V., Desai, M. J., Parikh, S., Nakamura, L. Y., Phillips, T. M., & Gerber, L. H. (2008). Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Archives of physical medicine and rehabilitation, 89(1), 16-23.
  3. Clauw, D. J. (2014). Fibromyalgia: a clinical review. Jama, 311(15), 1547-1555.
  4. Lund, N., Bengtsson, A., & Thorborg, P. (2010). Muscle tissue oxygen pressure in primary fibromyalgia. Scandinavian journal of rheumatology, 20(4), 282-287.
  5. Alvarez, D. J., & Rockwell, P. G. (2002). Trigger points: diagnosis and management. American Family Physician, 65(4), 653-660.
  6. Wolfe, F., Clauw, D. J., Fitzcharles, M. A., Goldenberg, D. L., Katz, R. S., Mease, P., … & Yunus, M. B. (2010). The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis care & research, 62(5), 600-610.
  7. Turrina, A., Martínez-González, M. A., & Stecco, C. (2013). The muscular force transmission system: role of the intramuscular connective tissue. Journal of bodywork and movement therapies, 17(1), 95-102.
  8. Shah, J. P., & Gilliams, E. A. (2008). Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis: an application of muscle pain concepts to myofascial pain syndrome. Journal of bodywork and movement therapies, 12(4), 371-384.